Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Hepatocellular 17 Stomach Neoplasms 9 Colorectal Neoplasms 7 Carcinoma, Non-Small-Cell Lung 7 Rectal Neoplasms 5 Neoplasm Metastasis 4 Triple Negative Breast Neoplasms 3 Pancreatic Neoplasms 3 Nasopharyngeal Carcinoma 3 Esophageal Squamous Cell Carcinoma 3 Esophageal Neoplasms 3 Uterine Cervical Neoplasms 2 Solid Tumor 2 Recurrence 2 Neoplasms 2 Lung Neoplasms 2 Endometrial Neoplasms 2 Thyroid Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Spinocerebellar Degenerations 1 Small Cell Lung Carcinoma 1 Resectable NSCLC 1 Ovarian Neoplasms 1 Neuroblastoma 1 Neoplasms, Unknown Primary 1 Metastatic Gastroesophageal Junction Adenocarcinoma 1 Meningeal Carcinomatosis 1 MSI-H 1 Lymphoma, T-Cell, Peripheral 1 Lymphoma, Mantle-Cell 1

Interventions

apatinib 2 Hyperthermic Intraperitoneal Chemotherapy 2 Gastrectomy 2 trastuzumab deruxtecan 1 taxane 1 sintilimab 1 pembrolizumab 1 durvalumab 1 disitamab vedotin 1 cabozantinib 1 Taxes 1 Tadalafil 1 SHR-1701 1 S 1 (combination) 1 Platinum 1 Paclitaxel 1 Oxaliplatin 1 Magnetic Resonance Spectroscopy 1 Indocyanine Green 1 Immunotherapy, Adoptive 1 Cytoreduction Surgical Procedures 1 Cisplatin 1 Albumin-Bound Paclitaxel 1 130-nm albumin-bound paclitaxel 1 1,2-diaminocyclohexaneplatinum II citrate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Gastric Adenocarcinoma × sintilimab × 1 year × Clear all

NCT07263386 2025-12-04

ARTEMIS-GC3

The First Affiliated Hospital with Nanjing Medical University

Phase 2 Recruiting

Gastrointestinal

Gastric Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡